The Food and Drug Administration (FDA) has announced the revocation of the Emergency Use Authorization granted to B. Braun Medical, Inc. This authorization was for the Perfusor Space Syringe Infusion Pump System, Infusomat Space Volumetric Infusion Pump System, and Outlook ES, which were initially approved for emergency use during the COVID-19 pandemic. The revocation, effective October 1, 2024, follows a request from B. Braun Medical, Inc., due to a lack of customer demand and the improved COVID-19 situation. This decision ensures public health and safety is maintained.
Simple Explanation
The FDA took back special permission they gave to a company for using certain medical pumps during COVID-19 because people aren't using them much anymore, and the COVID situation is better now.